These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity. D'Cruz D; Direskeneli H; Khamashta M; Hughes GR J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249 [TBL] [Abstract][Full Text] [Related]
7. Serum soluble CD4 and CD8 levels in polymyalgia rheumatica. Salvarani C; Boiardi L; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Portioli I J Rheumatol; 1994 Oct; 21(10):1865-9. PubMed ID: 7837152 [TBL] [Abstract][Full Text] [Related]
8. Serum soluble interleukin 2 receptor alpha and soluble CD8 levels in patients with gynecological malignancies undergoing radiotherapy. Frydecka I; Rusiecka M; Kuliczkowski K; Kornafel J Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):123-6. PubMed ID: 8915516 [TBL] [Abstract][Full Text] [Related]
9. [Levels of soluble intracellular adhesion molecules 1 (sICAM-1) , soluble receptors for interleukin 2 (sIL-2R) and anti-Epstein-Barr viral capsid antigen (anti-VCA IgM) in blood serum during the course of infectious mononucleosis]. Tomasiewicz K; Modrzewska R; Ćyczak A; Lis J Wiad Lek; 2001; 54(3-4):171-8. PubMed ID: 11436683 [TBL] [Abstract][Full Text] [Related]
10. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus. Srivastava MD; Rossi TM; Lebenthal E Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726 [TBL] [Abstract][Full Text] [Related]
11. Soluble IL-2-receptor and CD8 in the serum and the periparasitic granuloma of patients with alveolar echinococcosis. Bresson-Hadni S; Monnot-Jacquard B; Racadot E; Lenys D; Miguet JP; Vuitton DA Eur Cytokine Netw; 1991; 2(5):339-44. PubMed ID: 1804323 [TBL] [Abstract][Full Text] [Related]
12. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia. Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102 [TBL] [Abstract][Full Text] [Related]
13. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites. Elg SA; Hill RB; Heldman L; Ramakrishnan S Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933 [TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis. Carrieri PB; Soscia E; Iacovitti B; Pellicano M; D'Antonio A; Provitera V; Perrella O Eur Cytokine Netw; 1992; 3(5):495-8. PubMed ID: 1477299 [TBL] [Abstract][Full Text] [Related]
15. Elevated in vivo and in vitro secretion of CD8-alpha molecules in patients with systemic lupus erythematosus. Linker-Israeli M; Hyun S; Ozeri-Chen T; Wallace DJ; Banks K; Klinenberg JR J Immunol; 1994 Mar; 152(6):3158-67. PubMed ID: 8144910 [TBL] [Abstract][Full Text] [Related]
16. Soluble CD8 during T cell activation. Tomkinson BE; Brown MC; Ip SH; Carrabis S; Sullivan JL J Immunol; 1989 Apr; 142(7):2230-6. PubMed ID: 2784457 [TBL] [Abstract][Full Text] [Related]
17. T cell activation in vivo by dengue virus infection. Kurane I; Innis BL; Hoke CH; Eckels KH; Meager A; Janus J; Ennis FA J Clin Lab Immunol; 1995; 46(1):35-40. PubMed ID: 9363590 [TBL] [Abstract][Full Text] [Related]
18. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis. Hudnall SD; Patel J; Schwab H; Martinez J Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956 [TBL] [Abstract][Full Text] [Related]
19. CD8 lymphocytes during Epstein Barr virus (EBV) infection: A CD29 positive population is expanded in acute infectious mononucleosis. de Paoli P; Gennari D; Reitano M; Martelli P; Sacilotto C; Comoretto R; Santini G Allergol Immunopathol (Madr); 1991; 19(2):95-7. PubMed ID: 1722959 [TBL] [Abstract][Full Text] [Related]
20. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy. Dejica D Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]